{
  "url": "https://en.wikipedia.org/wiki/BenevolentAI",
  "title": "BenevolentAI",
  "html": "<!DOCTYPE html>\n<html class=\"client-nojs\" dir=\"ltr\" lang=\"en\">\n<head>\n<meta charset=\"utf-8\"/>\n<title>BenevolentAI - Wikipedia</title>\n<script>document.documentElement.className = document.documentElement.className.replace( /(^|\\s)client-nojs(\\s|$)/, \"$1client-js$2\" );</script>\n<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgCanonicalNamespace\":\"\",\"wgCanonicalSpecialPageName\":false,\"wgNamespaceNumber\":0,\"wgPageName\":\"BenevolentAI\",\"wgTitle\":\"BenevolentAI\",\"wgCurRevisionId\":884887073,\"wgRevisionId\":884887073,\"wgArticleId\":58865653,\"wgIsArticle\":true,\"wgIsRedirect\":false,\"wgAction\":\"view\",\"wgUserName\":null,\"wgUserGroups\":[\"*\"],\"wgCategories\":[\"Articles with short description\",\"Articles with a promotional tone from December 2018\",\"All articles with a promotional tone\",\"Wikipedia articles with undisclosed paid content from February 2019\",\"Artificial intelligence\",\"Companies of the United Kingdom\",\"Health informatics\"],\"wgBreakFrames\":false,\"wgPageContentLanguage\":\"en\",\"wgPageContentModel\":\"wikitext\",\"wgSeparatorTransformTable\":[\"\",\"\"],\"wgDigitTransformTable\":[\"\",\"\"],\"wgDefaultDateFormat\":\"dmy\",\"wgMonthNames\":[\"\",\"January\",\"February\",\"March\",\"April\",\"May\",\"June\",\"July\",\"August\",\"September\",\"October\",\"November\",\"December\"],\"wgMonthNamesShort\":[\"\",\"Jan\",\"Feb\",\"Mar\",\"Apr\",\"May\",\"Jun\",\"Jul\",\"Aug\",\"Sep\",\"Oct\",\"Nov\",\"Dec\"],\"wgRelevantPageName\":\"BenevolentAI\",\"wgRelevantArticleId\":58865653,\"wgRequestId\":\"XHLYfApAIC0AAIJOtM0AAACY\",\"wgCSPNonce\":false,\"wgIsProbablyEditable\":true,\"wgRelevantPageIsProbablyEditable\":true,\"wgRestrictionEdit\":[],\"wgRestrictionMove\":[],\"wgFlaggedRevsParams\":{\"tags\":{}},\"wgStableRevisionId\":null,\"wgCategoryTreePageCategoryOptions\":\"{\\\"mode\\\":0,\\\"hideprefix\\\":20,\\\"showcount\\\":true,\\\"namespaces\\\":false}\",\"wgWikiEditorEnabledModules\":[],\"wgBetaFeaturesFeatures\":[],\"wgMediaViewerOnClick\":true,\"wgMediaViewerEnabledByDefault\":true,\"wgPopupsShouldSendModuleToUser\":true,\"wgPopupsConflictsWithNavPopupGadget\":false,\"wgVisualEditor\":{\"pageLanguageCode\":\"en\",\"pageLanguageDir\":\"ltr\",\"pageVariantFallbacks\":\"en\",\"usePageImages\":true,\"usePageDescriptions\":true},\"wgMFIsPageContentModelEditable\":true,\"wgMFEnableFontChanger\":true,\"wgMFDisplayWikibaseDescriptions\":{\"search\":true,\"nearby\":true,\"watchlist\":true,\"tagline\":false},\"wgRelatedArticles\":null,\"wgRelatedArticlesUseCirrusSearch\":true,\"wgRelatedArticlesOnlyUseCirrusSearch\":false,\"wgWMESchemaEditAttemptStepOversample\":false,\"wgPoweredByHHVM\":true,\"wgULSCurrentAutonym\":\"English\",\"wgNoticeProject\":\"wikipedia\",\"wgCentralNoticeCookiesToDelete\":[],\"wgCentralNoticeCategoriesUsingLegacy\":[\"Fundraising\",\"fundraising\"],\"wgWikibaseItemId\":\"Q60750092\",\"wgScoreNoteLanguages\":{\"arabic\":\"العربية\",\"catalan\":\"català\",\"deutsch\":\"Deutsch\",\"english\":\"English\",\"espanol\":\"español\",\"italiano\":\"italiano\",\"nederlands\":\"Nederlands\",\"norsk\":\"norsk\",\"portugues\":\"português\",\"suomi\":\"suomi\",\"svenska\":\"svenska\",\"vlaams\":\"West-Vlams\"},\"wgScoreDefaultNoteLanguage\":\"nederlands\",\"wgCentralAuthMobileDomain\":false,\"wgCodeMirrorEnabled\":true,\"wgVisualEditorToolbarScrollOffset\":0,\"wgVisualEditorUnsupportedEditParams\":[\"undo\",\"undoafter\",\"veswitched\"],\"wgEditSubmitButtonLabelPublish\":true,\"oresWikiId\":\"enwiki\",\"oresBaseUrl\":\"http://ores.discovery.wmnet:8081/\",\"oresApiVersion\":3});mw.loader.state({\"ext.gadget.charinsert-styles\":\"ready\",\"ext.globalCssJs.user.styles\":\"ready\",\"ext.globalCssJs.site.styles\":\"ready\",\"site.styles\":\"ready\",\"noscript\":\"ready\",\"user.styles\":\"ready\",\"ext.globalCssJs.user\":\"ready\",\"ext.globalCssJs.site\":\"ready\",\"user\":\"ready\",\"user.options\":\"ready\",\"user.tokens\":\"loading\",\"ext.cite.styles\":\"ready\",\"mediawiki.legacy.shared\":\"ready\",\"mediawiki.legacy.commonPrint\":\"ready\",\"mediawiki.toc.styles\":\"ready\",\"wikibase.client.init\":\"ready\",\"ext.visualEditor.desktopArticleTarget.noscript\":\"ready\",\"ext.uls.interlanguage\":\"ready\",\"ext.wikimediaBadges\":\"ready\",\"ext.3d.styles\":\"ready\",\"mediawiki.skinning.interface\":\"ready\",\"skins.vector.styles\":\"ready\"});mw.loader.implement(\"user.tokens@0tffind\",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({\"editToken\":\"+\\\\\",\"patrolToken\":\"+\\\\\",\"watchToken\":\"+\\\\\",\"csrfToken\":\"+\\\\\"});\n});RLPAGEMODULES=[\"ext.cite.ux-enhancements\",\"site\",\"mediawiki.page.startup\",\"mediawiki.page.ready\",\"mediawiki.toc\",\"mediawiki.searchSuggest\",\"ext.gadget.teahouse\",\"ext.gadget.ReferenceTooltips\",\"ext.gadget.watchlist-notice\",\"ext.gadget.DRN-wizard\",\"ext.gadget.charinsert\",\"ext.gadget.refToolbar\",\"ext.gadget.extra-toolbar-buttons\",\"ext.gadget.switcher\",\"ext.centralauth.centralautologin\",\"mmv.head\",\"mmv.bootstrap.autostart\",\"ext.popups\",\"ext.visualEditor.desktopArticleTarget.init\",\"ext.visualEditor.targetLoader\",\"ext.eventLogging\",\"ext.wikimediaEvents\",\"ext.navigationTiming\",\"ext.uls.eventlogger\",\"ext.uls.init\",\"ext.uls.compactlinks\",\"ext.uls.interface\",\"ext.quicksurveys.init\",\"ext.centralNotice.geoIP\",\"ext.centralNotice.startUp\",\"skins.vector.js\"];mw.loader.load(RLPAGEMODULES);});</script>\n<link href=\"/w/load.php?debug=false&amp;lang=en&amp;modules=ext.3d.styles%7Cext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.skinning.interface%7Cmediawiki.toc.styles%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector\" rel=\"stylesheet\"/>\n<script async=\"\" src=\"/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector\"></script>\n<meta content=\"\" name=\"ResourceLoaderDynamicStyles\"/>\n<link href=\"/w/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.charinsert-styles&amp;only=styles&amp;skin=vector\" rel=\"stylesheet\"/>\n<link href=\"/w/load.php?debug=false&amp;lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector\" rel=\"stylesheet\"/>\n<meta content=\"MediaWiki 1.33.0-wmf.18\" name=\"generator\"/>\n<meta content=\"origin\" name=\"referrer\"/>\n<meta content=\"origin-when-crossorigin\" name=\"referrer\"/>\n<meta content=\"origin-when-cross-origin\" name=\"referrer\"/>\n<link href=\"android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/BenevolentAI\" rel=\"alternate\"/>\n<link href=\"/w/index.php?title=BenevolentAI&amp;action=edit\" rel=\"alternate\" title=\"Edit this page\" type=\"application/x-wiki\"/>\n<link href=\"/w/index.php?title=BenevolentAI&amp;action=edit\" rel=\"edit\" title=\"Edit this page\"/>\n<link href=\"/static/apple-touch/wikipedia.png\" rel=\"apple-touch-icon\"/>\n<link href=\"/static/favicon/wikipedia.ico\" rel=\"shortcut icon\"/>\n<link href=\"/w/opensearch_desc.php\" rel=\"search\" title=\"Wikipedia (en)\" type=\"application/opensearchdescription+xml\"/>\n<link href=\"//en.wikipedia.org/w/api.php?action=rsd\" rel=\"EditURI\" type=\"application/rsd+xml\"/>\n<link href=\"//creativecommons.org/licenses/by-sa/3.0/\" rel=\"license\"/>\n<link href=\"https://en.wikipedia.org/wiki/BenevolentAI\" rel=\"canonical\"/>\n<link href=\"//login.wikimedia.org\" rel=\"dns-prefetch\"/>\n<link href=\"//meta.wikimedia.org\" rel=\"dns-prefetch\"/>\n<!--[if lt IE 9]><script src=\"/w/load.php?debug=false&amp;lang=en&amp;modules=html5shiv&amp;only=scripts&amp;skin=vector&amp;sync=1\"></script><![endif]-->\n</head>\n<body class=\"mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-BenevolentAI rootpage-BenevolentAI skin-vector action-view\"> <div class=\"noprint\" id=\"mw-page-base\"></div>\n<div class=\"noprint\" id=\"mw-head-base\"></div>\n<div class=\"mw-body\" id=\"content\" role=\"main\">\n<a id=\"top\"></a>\n<div class=\"mw-body-content\" id=\"siteNotice\"><!-- CentralNotice --></div><div class=\"mw-indicators mw-body-content\">\n</div>\n<h1 class=\"firstHeading\" id=\"firstHeading\" lang=\"en\">BenevolentAI</h1> <div class=\"mw-body-content\" id=\"bodyContent\">\n<div class=\"noprint\" id=\"siteSub\">From Wikipedia, the free encyclopedia</div> <div id=\"contentSub\"></div>\n<div id=\"jump-to-nav\"></div> <a class=\"mw-jump-link\" href=\"#mw-head\">Jump to navigation</a>\n<a class=\"mw-jump-link\" href=\"#p-search\">Jump to search</a>\n<div class=\"mw-content-ltr\" dir=\"ltr\" id=\"mw-content-text\" lang=\"en\"><div class=\"mw-parser-output\"><div class=\"shortdescription nomobile noexcerpt noprint searchaux\" style=\"display:none\">UK-based artificial intelligence company</div>\n<table class=\"box-Advert plainlinks metadata ambox ambox-content ambox-Advert\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" data-file-height=\"40\" data-file-width=\"40\" decoding=\"async\" height=\"40\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x\" width=\"40\"/></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>contains content that is written like <a href=\"/wiki/Wikipedia:What_Wikipedia_is_not#Wikipedia_is_not_a_soapbox_or_means_of_promotion\" title=\"Wikipedia:What Wikipedia is not\">an advertisement</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=BenevolentAI&amp;action=edit\">improve it</a> by removing <a href=\"/wiki/Wikipedia:Spam\" title=\"Wikipedia:Spam\">promotional content</a> and inappropriate <a href=\"/wiki/Wikipedia:External_links\" title=\"Wikipedia:External links\">external links</a>, and by adding encyclopedic content written from a <a href=\"/wiki/Wikipedia:Neutral_point_of_view\" title=\"Wikipedia:Neutral point of view\">neutral point of view</a>.</span> <small class=\"date-container\"><i>(<span class=\"date\">December 2018</span>)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"box-Undisclosed_paid plainlinks metadata ambox ambox-delete\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"Dollar sign in circle cleaned (PD version).svg\" data-file-height=\"512\" data-file-width=\"512\" decoding=\"async\" height=\"50\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Dollar_sign_in_circle_cleaned_%28PD_version%29.svg/50px-Dollar_sign_in_circle_cleaned_%28PD_version%29.svg.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Dollar_sign_in_circle_cleaned_%28PD_version%29.svg/75px-Dollar_sign_in_circle_cleaned_%28PD_version%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Dollar_sign_in_circle_cleaned_%28PD_version%29.svg/100px-Dollar_sign_in_circle_cleaned_%28PD_version%29.svg.png 2x\" width=\"50\"/></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\"><b>This article may have been created or edited in return for undisclosed payments</b>, a violation of Wikipedia's <a class=\"extiw\" href=\"https://foundation.wikimedia.org/wiki/Terms_of_Use\" title=\"wmf:Terms of Use\">terms of use</a>.<span class=\"hide-when-compact\"> It may require <a href=\"/wiki/Wikipedia:Cleanup\" title=\"Wikipedia:Cleanup\">cleanup</a> to comply with Wikipedia's <b><a href=\"/wiki/Wikipedia:List_of_policies#Content\" title=\"Wikipedia:List of policies\">content policies</a></b>.</span> <small class=\"date-container\"><i>(<span class=\"date\">February 2019</span>)</i></small></div></td></tr></tbody></table>\n<table class=\"infobox vcard\" style=\"width:22em\"><caption class=\"fn org\">BenevolentAI</caption><tbody><tr><td class=\"logo\" colspan=\"2\" style=\"text-align:center\"><a class=\"image\" href=\"/wiki/File:BenevolentAI_logo.png\"><img alt=\"BenevolentAI logo.png\" data-file-height=\"113\" data-file-width=\"447\" decoding=\"async\" height=\"56\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/BenevolentAI_logo.png/220px-BenevolentAI_logo.png\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/BenevolentAI_logo.png/330px-BenevolentAI_logo.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fb/BenevolentAI_logo.png/440px-BenevolentAI_logo.png 2x\" width=\"220\"/></a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\"><a href=\"/wiki/List_of_legal_entity_types_by_country\" title=\"List of legal entity types by country\">Type</a></div></th><td class=\"category\" style=\"line-height:1.35em;\"><a href=\"/wiki/Privately_held_company\" title=\"Privately held company\">Private</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\"><a href=\"/wiki/Ticker_symbol\" title=\"Ticker symbol\">Traded as</a></th><td style=\"line-height:1.35em;\">NYSE: FTCH</td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\">Industry</th><td class=\"category\" style=\"line-height:1.35em;\"><a href=\"/wiki/Artificial_intelligence\" title=\"Artificial intelligence\">Artificial intelligence</a><br/><a href=\"/wiki/Health_care\" title=\"Health care\">Health care</a><br/><a href=\"/wiki/Neuroscience\" title=\"Neuroscience\">Neuroscience</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\">Founded</th><td style=\"line-height:1.35em;\">November 13, 2013</td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\">Headquarters</th><td class=\"adr\" style=\"line-height:1.35em;\"><div class=\"locality\" style=\"display:inline\"><a class=\"mw-redirect\" href=\"/wiki/London,_England\" title=\"London, England\">London, England</a></div></td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Key people</div></th><td class=\"agent\" style=\"line-height:1.35em;\">Brent Gutekunst, Ivan Griffin, Ken Mulvany, Michael Brennan, CEO, Baroness Joanna Shields</td></tr><tr><th scope=\"row\" style=\"padding-right:0.5em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Number of employees</div></th><td style=\"line-height:1.35em;\">200 – 250</td></tr></tbody></table>\n<p><b>BenevolentAI</b> is a UK-based <a href=\"/wiki/Artificial_intelligence\" title=\"Artificial intelligence\">artificial intelligence</a> company. They operate under the mission to change the way medicine is designed, developed, tested, and delivered to the market using computational medicine and AI technology.<sup class=\"reference\" id=\"cite_ref-1\"><a href=\"#cite_note-1\">[1]</a></sup> It is a fully integrated AI company with pharmaceutical discovery and clinical development capabilities.<sup class=\"reference\" id=\"cite_ref-2\"><a href=\"#cite_note-2\">[2]</a></sup>\n</p><p>The company has developed the Benevolent Platform, an end-to-end computational and experimental platform for drug discovery; BenevolentAI scientists use the platform to find new ways to treat disease and personalise drugs to patients.<sup class=\"reference\" id=\"cite_ref-3\"><a href=\"#cite_note-3\">[3]</a></sup> The Benevolent Platform continuously ingests and analyses unstructured and structured biomedical information, from academic papers to compound databases, to clinical trials, to scientific patents. This information is combined with deep learning to create a bioscience knowledge graph coupled with an automated platform for hypothesis generation and validation followed by the design, refinement and synthesis of molecules.<sup class=\"reference\" id=\"cite_ref-4\"><a href=\"#cite_note-4\">[4]</a></sup>\n</p>\n<div class=\"toc\" id=\"toc\"><input class=\"toctogglecheckbox\" id=\"toctogglecheckbox\" role=\"button\" style=\"display:none\" type=\"checkbox\"/><div class=\"toctitle\" dir=\"ltr\" lang=\"en\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Company_history\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Company history</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Solutions_and_services\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Solutions and services</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#BenevolentAI_Award\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">BenevolentAI Award</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Awards_and_recognitions\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Awards and recognitions</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"Company_history\">Company history</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BenevolentAI&amp;action=edit&amp;section=1\" title=\"Edit section: Company history\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>BenevolentAI was founded in November 2013 by Ken Mulvany.<sup class=\"reference\" id=\"cite_ref-5\"><a href=\"#cite_note-5\">[5]</a></sup> Initially the company focussed on the development of a cross functional AI technology to incorporate basic science, chemistry and clinical components and designed a system that could ingest, read and contextualise the world’s available bioscience information.<sup class=\"reference\" id=\"cite_ref-6\"><a href=\"#cite_note-6\">[6]</a></sup>\n</p><p>Throughout the course of 2014 and 2015 the technology was further developed to also reason and propose hypotheses to treat disease. By 2015, the company had raised $87 million in funding, including investors like Woodford Investment Management and Lansdowne Partners.<sup class=\"reference\" id=\"cite_ref-7\"><a href=\"#cite_note-7\">[7]</a></sup> In 2015 BenevolentAI began to fully apply its technology to drug discovery and development and announced the appointment of Jackie Hunter to lead bioscience research at the company.<sup class=\"reference\" id=\"cite_ref-8\"><a href=\"#cite_note-8\">[8]</a></sup>\n</p><p>During 2016 further early drug R&amp;D programmes were established and an in-license deal completed with J&amp;J for novel clinical stage drug candidates.<sup class=\"reference\" id=\"cite_ref-9\"><a href=\"#cite_note-9\">[9]</a></sup> That year BenevolentAI also initiated their first full drug programmes for ALS, and indicated in a later press release positive results from the initial data.<sup class=\"reference\" id=\"cite_ref-10\"><a href=\"#cite_note-10\">[10]</a></sup>\n</p><p><br/>\n2017 saw the company file its first Investigational New Drug (IND) application. In February 2018, BenevolentAI acquired a Cambridge research facility in order to expand its capabilities across the entire drug discovery process. Two months later the company announced a further round of funding for $115 million.<sup class=\"reference\" id=\"cite_ref-11\"><a href=\"#cite_note-11\">[11]</a></sup> In May of 2018, the company announced it had appointed <a class=\"mw-redirect\" href=\"/wiki/Joanna_Shields\" title=\"Joanna Shields\">Joanna Shields</a> as CEO.<sup class=\"reference\" id=\"cite_ref-12\"><a href=\"#cite_note-12\">[12]</a></sup>\n</p><p>The company is presently headquartered in Warren Street, London with a research facility in Cambridge (UK) and additional offices based in New York and Belgium.<sup class=\"reference\" id=\"cite_ref-13\"><a href=\"#cite_note-13\">[13]</a></sup> On keeping the company headquartered in London, founder Mulvany has said “There's a real opportunity to build a business in this country, and there's an opportunity for the country to lead this sector, and all the pieces are in place. We've got incredible scientists, incredible mathematicians, we're able to draw all these people into London.\"<sup class=\"reference\" id=\"cite_ref-14\"><a href=\"#cite_note-14\">[14]</a></sup> BenevolentAI has active R&amp;D drug programmes from discovery to PhaseIIb in disease areas such as <a class=\"mw-redirect\" href=\"/wiki/ALS\" title=\"ALS\">ALS</a>, <a class=\"mw-redirect\" href=\"/wiki/Parkinson%E2%80%99s\" title=\"Parkinson’s\">Parkinson’s</a>, <a href=\"/wiki/Ulcerative_colitis\" title=\"Ulcerative colitis\">ulcerative colitis</a> and <a href=\"/wiki/Sarcopenia\" title=\"Sarcopenia\">sarcopenia</a>.<sup class=\"reference\" id=\"cite_ref-15\"><a href=\"#cite_note-15\">[15]</a></sup>\nHorizons Ventures advisor Bart Swanson is a board member; shareholders include Richard Farleigh, a high profile angel investor.<sup class=\"reference\" id=\"cite_ref-16\"><a href=\"#cite_note-16\">[16]</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Solutions_and_services\">Solutions and services</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BenevolentAI&amp;action=edit&amp;section=2\" title=\"Edit section: Solutions and services\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In 2016 BenevolentAI became the first European company to use a deep learning supercomputer to assist in the process of drug discovery, using the DGX-1 supercomputer to support its Judgment Augmented Correlation System (JACS).<sup class=\"reference\" id=\"cite_ref-17\"><a href=\"#cite_note-17\">[17]</a></sup> The BenevolentAI Platform ingests data, reads, synthesizes, and contextualises data to determine the cause of a disease, proposes a drug target, makes a molecule to treat that disease and then defines the right patients to test that molecule in to drive greater clinical success.<sup class=\"reference\" id=\"cite_ref-18\"><a href=\"#cite_note-18\">[18]</a></sup>\n</p><p>Their Platform is specifically used to design new molecules and extract hypotheses based on a knowledge graph detailing the relationships between genes, targets, diseases, proteins, and drugs.<sup class=\"reference\" id=\"cite_ref-19\"><a href=\"#cite_note-19\">[19]</a></sup> The company has announced it is working with the Sheffield Institute of Translational Neuroscience on a treatment for ALS.<sup class=\"reference\" id=\"cite_ref-20\"><a href=\"#cite_note-20\">[20]</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"BenevolentAI_Award\">BenevolentAI Award</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BenevolentAI&amp;action=edit&amp;section=3\" title=\"Edit section: BenevolentAI Award\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In 2017 BenevolentAI announced the creation of the BenevolentAI Award, in partnership with the Association of Medical Research Charities. The award is given to a single applicant a year, allowing the winner to access the company’s technology to accelerate their medical research using artificial intelligence.<sup class=\"reference\" id=\"cite_ref-21\"><a href=\"#cite_note-21\">[21]</a></sup>\n</p><p>The winner of the 2018 award was a collaboration between the Parkinson’s UK and The Cure Parkinson’s Trust. Upon receiving the award, the group announced their aim to identify three treatments that can be repurposed for Parkinson’s and two novel drug targets.<sup class=\"reference\" id=\"cite_ref-22\"><a href=\"#cite_note-22\">[22]</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Awards_and_recognitions\">Awards and recognitions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BenevolentAI&amp;action=edit&amp;section=4\" title=\"Edit section: Awards and recognitions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<dl><dt>2017</dt></dl>\n<ul><li>CB Insights, “AI 100”<sup class=\"reference\" id=\"cite_ref-23\"><a href=\"#cite_note-23\">[23]</a></sup></li>\n<li>Sunday Times Tech Track, “Ones to Watch”<sup class=\"reference\" id=\"cite_ref-24\"><a href=\"#cite_note-24\">[24]</a></sup></li>\n<li>CPhI Awards Excellence in Pharma, “Pharma Company of the Year SME”<sup class=\"reference\" id=\"cite_ref-25\"><a href=\"#cite_note-25\">[25]</a></sup></li>\n<li>The Europas, “Hottest AI Start-Up”<sup class=\"reference\" id=\"cite_ref-26\"><a href=\"#cite_note-26\">[26]</a></sup></li></ul>\n<dl><dt>2018</dt></dl>\n<ul><li>CogX, “Best AI Product in Healthcare”<sup class=\"reference\" id=\"cite_ref-27\"><a href=\"#cite_note-27\">[27]</a></sup></li>\n<li>World Economic Forum, “Technology Pioneer Status”<sup class=\"reference\" id=\"cite_ref-28\"><a href=\"#cite_note-28\">[28]</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=BenevolentAI&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://benevolent.ai/about-us\" rel=\"nofollow\">\"About Us\"</a>. <i>BenevolentAI</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BenevolentAI&amp;rft.atitle=About+Us&amp;rft_id=https%3A%2F%2Fbenevolent.ai%2Fabout-us&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><style data-mw-deduplicate=\"TemplateStyles:r879151008\">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:\"\\\"\"\"\\\"\"\"'\"\"'\"}.mw-parser-output .citation .cs1-lock-free a{background:url(\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url(\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png\")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url(\"//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png\")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url(\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png\")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://www.prnewswire.com/news-releases/benevolentai-raises-115-million-to-extend-its-leading-global-position-in-the-field-of-ai-enabled-drug-development-680180573.html\" rel=\"nofollow\">\"BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development\"</a>. <i>PR Newswire</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PR+Newswire&amp;rft.atitle=BenevolentAI+Raises+%24115+Million+to+Extend+Its+Leading+Global+Position+in+the+Field+of+AI+Enabled+Drug+Development&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fbenevolentai-raises-115-million-to-extend-its-leading-global-position-in-the-field-of-ai-enabled-drug-development-680180573.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Liu, Angus. <a class=\"external text\" href=\"https://www.fiercebiotech.com/biotech/proximagen-buy-creates-first-ai-firm-capable-entire-drug-r-d-benevolentai\" rel=\"nofollow\">\"BenevolentAI's Proximagen buy creates first AI firm capable of entire drug R&amp;D\"</a>. <i>Fierce Biotech</i>. Questex<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fierce+Biotech&amp;rft.atitle=BenevolentAI%27s+Proximagen+buy+creates+first+AI+firm+capable+of+entire+drug+R%26D&amp;rft.aulast=Liu&amp;rft.aufirst=Angus&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fproximagen-buy-creates-first-ai-firm-capable-entire-drug-r-d-benevolentai&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Shields, Joanna. <a class=\"external text\" href=\"https://benevolent.ai/blog/why-we-need-to-use-ai-for-life-not-just-lifestyle1\" rel=\"nofollow\">\"Why we need to use AI for life not just lifestyle\"</a>. <i>BenevolentAI</i>. BenevolentAI<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BenevolentAI&amp;rft.atitle=Why+we+need+to+use+AI+for+life+not+just+lifestyle&amp;rft.aulast=Shields&amp;rft.aufirst=Joanna&amp;rft_id=https%3A%2F%2Fbenevolent.ai%2Fblog%2Fwhy-we-need-to-use-ai-for-life-not-just-lifestyle1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Lunden, Ingrid. <a class=\"external text\" href=\"https://techcrunch.com/2018/04/18/benevolentai-which-uses-ai-to-develop-drugs-and-energy-solutions-nabs-115m-at-2b-valuation/\" rel=\"nofollow\">\"BenevolentAI, which uses AI to develop drugs and energy solutions, nabs $115M at $2B valuation\"</a>. <i>TechCrunch</i>. TechCrunch<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=TechCrunch&amp;rft.atitle=BenevolentAI%2C+which+uses+AI+to+develop+drugs+and+energy+solutions%2C+nabs+%24115M+at+%242B+valuation&amp;rft.aulast=Lunden&amp;rft.aufirst=Ingrid&amp;rft_id=https%3A%2F%2Ftechcrunch.com%2F2018%2F04%2F18%2Fbenevolentai-which-uses-ai-to-develop-drugs-and-energy-solutions-nabs-115m-at-2b-valuation%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">BenevolentAI. <a class=\"external text\" href=\"https://www.prnewswire.com/news-releases/benevolentai-raises-115-million-to-extend-its-leading-global-position-in-the-field-of-ai-enabled-drug-development-680180573.html\" rel=\"nofollow\">\"BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development\"</a>. <i>PR Newswire</i>. Cision<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PR+Newswire&amp;rft.atitle=BenevolentAI+Raises+%24115+Million+to+Extend+Its+Leading+Global+Position+in+the+Field+of+AI+Enabled+Drug+Development&amp;rft.au=BenevolentAI&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fbenevolentai-raises-115-million-to-extend-its-leading-global-position-in-the-field-of-ai-enabled-drug-development-680180573.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Taylor, Nick Paul. <a class=\"external text\" href=\"https://www.fiercebiotech.com/medtech/benevolentai-bags-115m-to-fuel-ai-enabled-r-d-push\" rel=\"nofollow\">\"MedTech BenevolentAI bags $115M to fuel AI-enabled R&amp;D push\"</a>. <i>Fierce Biotech</i>. Questex<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fierce+Biotech&amp;rft.atitle=MedTech+BenevolentAI+bags+%24115M+to+fuel+AI-enabled+R%26D+push&amp;rft.aulast=Taylor&amp;rft.aufirst=Nick+Paul&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Fbenevolentai-bags-115m-to-fuel-ai-enabled-r-d-push&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">BenevolentAI. <a class=\"external text\" href=\"https://benevolent.ai/news/announcements/benevolentai-appoints-jackie-hunter-as-ceo-of-benevolentbio\" rel=\"nofollow\">\"BenevolentAI, the pioneering London-based company using artificial intelligence to advance pharmaceutical development, appoints head of BBSRC as new Chief Executive\"</a>. <i>BenevolentAI</i>. BenevolentAI<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BenevolentAI&amp;rft.atitle=BenevolentAI%2C+the+pioneering+London-based+company+using+artificial+intelligence+to+advance+pharmaceutical+development%2C+appoints+head+of+BBSRC+as+new+Chief+Executive&amp;rft.au=BenevolentAI&amp;rft_id=https%3A%2F%2Fbenevolent.ai%2Fnews%2Fannouncements%2Fbenevolentai-appoints-jackie-hunter-as-ceo-of-benevolentbio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://benevolent.ai/news/announcements/british-artificial-intelligence-firm-announces-exclusive-license-agreement-with-janssen\" rel=\"nofollow\">\"Exclusive license agreement with Janssen for clinical stage drug candidates\"</a>. <i>BenevolentAI</i>. BenevolentAI<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BenevolentAI&amp;rft.atitle=Exclusive+license+agreement+with+Janssen+for+clinical+stage+drug+candidates&amp;rft_id=https%3A%2F%2Fbenevolent.ai%2Fnews%2Fannouncements%2Fbritish-artificial-intelligence-firm-announces-exclusive-license-agreement-with-janssen&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://benevolent.ai/news/announcements/ai-enabled-research-shows-delay-in-onset-of-motor-neurone-disease\" rel=\"nofollow\">\"AI enabled research shows delay in onset of motor neurone disease\"</a>. <i>BenevolentAI</i>. BenevolentAI<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BenevolentAI&amp;rft.atitle=AI+enabled+research+shows+delay+in+onset+of+motor+neurone+disease&amp;rft_id=https%3A%2F%2Fbenevolent.ai%2Fnews%2Fannouncements%2Fai-enabled-research-shows-delay-in-onset-of-motor-neurone-disease&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Reuters. <a class=\"external text\" href=\"https://www.euronews.com/2018/04/19/ai-drug-hunter-benevolentai-worth-2-billion-after-fund-raising\" rel=\"nofollow\">\"AI drug hunter BenevolentAI worth $2 billion after fund raising\"</a>. <i>EuroNews</i>. EuroNews<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EuroNews&amp;rft.atitle=AI+drug+hunter+BenevolentAI+worth+%242+billion+after+fund+raising&amp;rft.au=Reuters&amp;rft_id=https%3A%2F%2Fwww.euronews.com%2F2018%2F04%2F19%2Fai-drug-hunter-benevolentai-worth-2-billion-after-fund-raising&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Shead, Sam. <a class=\"external text\" href=\"https://www.forbes.com/sites/samshead/2018/05/01/benevolentai-makes-joanna-shields-new-ceo/#54c99605b9cd\" rel=\"nofollow\">\"BenevolentAI Makes Joanna Shields New CEO\"</a>. <i>Forbes</i>. Forbes<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=BenevolentAI+Makes+Joanna+Shields+New+CEO&amp;rft.aulast=Shead&amp;rft.aufirst=Sam&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fsamshead%2F2018%2F05%2F01%2Fbenevolentai-makes-joanna-shields-new-ceo%2F%2354c99605b9cd&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Medeiros, João. <a class=\"external text\" href=\"https://www.wired.co.uk/article/benevolent-ai-london-unicorn-pharma-startup\" rel=\"nofollow\">\"This AI unicorn is disrupting the pharma industry in a big way\"</a>. <i>WIRED</i>. WIRED<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=WIRED&amp;rft.atitle=This+AI+unicorn+is+disrupting+the+pharma+industry+in+a+big+way&amp;rft.aulast=Medeiros&amp;rft.aufirst=Jo%C3%A3o&amp;rft_id=https%3A%2F%2Fwww.wired.co.uk%2Farticle%2Fbenevolent-ai-london-unicorn-pharma-startup&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Shona, Ghosh. <a class=\"external text\" href=\"https://www.businessinsider.com/benevolent-ai-ceo-ken-mulvany-interview-2017-4\" rel=\"nofollow\">\"A British tech unicorn is trying to cure Alzheimer's and ALS with artificial intelligence\"</a>. <i>Business Insider</i>. Business Insider<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Business+Insider&amp;rft.atitle=A+British+tech+unicorn+is+trying+to+cure+Alzheimer%27s+and+ALS+with+artificial+intelligence&amp;rft.aulast=Shona&amp;rft.aufirst=Ghosh&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fbenevolent-ai-ceo-ken-mulvany-interview-2017-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Brackley, Paul. <a class=\"external text\" href=\"http://www.cambridgeindependent.co.uk/business/science/benevolentai-founder-ken-mulvany-on-using-artificial-intelligence-to-find-new-drugs-to-tackle-disease-1-5429242\" rel=\"nofollow\">\"BenevolentAI founder Ken Mulvany on using artificial intelligence to find new drugs to tackle disease\"</a>. <i>Cambridge Independent</i>. Cambridge<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Cambridge+Independent&amp;rft.atitle=BenevolentAI+founder+Ken+Mulvany+on+using+artificial+intelligence+to+find+new+drugs+to+tackle+disease&amp;rft.aulast=Brackley&amp;rft.aufirst=Paul&amp;rft_id=http%3A%2F%2Fwww.cambridgeindependent.co.uk%2Fbusiness%2Fscience%2Fbenevolentai-founder-ken-mulvany-on-using-artificial-intelligence-to-find-new-drugs-to-tackle-disease-1-5429242&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Ghosh, Shona. <a class=\"external text\" href=\"https://www.businessinsider.com/benevolent-ai-ceo-ken-mulvany-interview-2017-4\" rel=\"nofollow\">\"A British tech unicorn is trying to cure Alzheimer's and ALS with artificial intelligence\"</a>. <i>Business Insider</i>. Business Insider<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Business+Insider&amp;rft.atitle=A+British+tech+unicorn+is+trying+to+cure+Alzheimer%27s+and+ALS+with+artificial+intelligence&amp;rft.aulast=Ghosh&amp;rft.aufirst=Shona&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fbenevolent-ai-ceo-ken-mulvany-interview-2017-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Staines, Richard. <a class=\"external text\" href=\"https://pharmaphorum.com/news/benevolentai-revolutionise-drug-rd-new-facility/\" rel=\"nofollow\">\"AI firm aims to revolutionise drug R&amp;D with new UK facility\"</a>. <i>pharmaphorum</i>. pharmaphorum<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=pharmaphorum&amp;rft.atitle=AI+firm+aims+to+revolutionise+drug+R%26D+with+new+UK+facility&amp;rft.aulast=Staines&amp;rft.aufirst=Richard&amp;rft_id=https%3A%2F%2Fpharmaphorum.com%2Fnews%2Fbenevolentai-revolutionise-drug-rd-new-facility%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://www.crunchbase.com/organization/benevolent-ai#section-overview\" rel=\"nofollow\">\"BenevolentAI\"</a>. <i>Crunchbase</i>. Crunchbase<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Crunchbase&amp;rft.atitle=BenevolentAI&amp;rft_id=https%3A%2F%2Fwww.crunchbase.com%2Forganization%2Fbenevolent-ai%23section-overview&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">BenevolentAI. <a class=\"external text\" href=\"https://www.prnewswire.com/news-releases/benevolentai-raises-115-million-to-extend-its-leading-global-position-in-the-field-of-ai-enabled-drug-development-680180573.html\" rel=\"nofollow\">\"BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development\"</a>. <i>Pr Newswire</i>. Cision<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pr+Newswire&amp;rft.atitle=BenevolentAI+Raises+%24115+Million+to+Extend+Its+Leading+Global+Position+in+the+Field+of+AI+Enabled+Drug+Development&amp;rft.au=BenevolentAI&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fbenevolentai-raises-115-million-to-extend-its-leading-global-position-in-the-field-of-ai-enabled-drug-development-680180573.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Rossi, Ben. <a class=\"external text\" href=\"https://www.information-age.com/ai-provides-breakthrough-treatment-motor-neuron-disease-123466452/\" rel=\"nofollow\">\"AI provides breakthrough in treatment for motor neuron disease\"</a>. <i>Information Age</i>. Bonhill<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Information+Age&amp;rft.atitle=AI+provides+breakthrough+in+treatment+for+motor+neuron+disease&amp;rft.aulast=Rossi&amp;rft.aufirst=Ben&amp;rft_id=https%3A%2F%2Fwww.information-age.com%2Fai-provides-breakthrough-treatment-motor-neuron-disease-123466452%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://benevolent.ai/news/announcements/medical-ai-award-sets-its-sights-on-treating-parkinsons\" rel=\"nofollow\">\"Annual award announced for medical research charities wishing to benefit from artificial intelligence\"</a>. <i>BenevolentAI</i>. BenevolentAI<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BenevolentAI&amp;rft.atitle=Annual+award+announced+for+medical+research+charities+wishing+to+benefit+from+artificial+intelligence&amp;rft_id=https%3A%2F%2Fbenevolent.ai%2Fnews%2Fannouncements%2Fmedical-ai-award-sets-its-sights-on-treating-parkinsons&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Hughes, Owen. <a class=\"external text\" href=\"https://www.digitalhealth.net/2018/04/benevolent-ai-lens-artificial-intelligence-platform/\" rel=\"nofollow\">\"British AI firm lends smarts to Parkinson's charities in hunt for new treatments\"</a>. <i>Digital Health</i>. Digital Health<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Digital+Health&amp;rft.atitle=British+AI+firm+lends+smarts+to+Parkinson%E2%80%99s+charities+in+hunt+for+new+treatments&amp;rft.aulast=Hughes&amp;rft.aufirst=Owen&amp;rft_id=https%3A%2F%2Fwww.digitalhealth.net%2F2018%2F04%2Fbenevolent-ai-lens-artificial-intelligence-platform%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://www.prnewswire.com/news-releases/cb-insights-reveals-the-ai-100-list-at-the-innovation-summit-610394035.html\" rel=\"nofollow\">\"CB Insights Reveals the AI 100 List At The Innovation Summit\"</a>. <i>PR Newswire</i>. Automat Technologies, Inc<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PR+Newswire&amp;rft.atitle=CB+Insights+Reveals+the+AI+100+List+At+The+Innovation+Summit&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcb-insights-reveals-the-ai-100-list-at-the-innovation-summit-610394035.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"http://www.fasttrack.co.uk/wp-content/uploads/2017-Sunday-Times-Hiscox-Tech-Track-100-National-press-release.pdf\" rel=\"nofollow\">\"BRITAIN'S FASTEST-GROWING PRIVATE TECH COMPANIES REVEALED\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Fast Track</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fast+Track&amp;rft.atitle=BRITAIN%E2%80%99S+FASTEST-GROWING+PRIVATE+TECH+COMPANIES+REVEALED&amp;rft_id=http%3A%2F%2Fwww.fasttrack.co.uk%2Fwp-content%2Fuploads%2F2017-Sunday-Times-Hiscox-Tech-Track-100-National-press-release.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://awards.cphi.com/winners/2017-winners/\" rel=\"nofollow\">\"Winners 2017\"</a>. <i>CPhI Pharma Awards</i>. UBM<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CPhI+Pharma+Awards&amp;rft.atitle=Winners+2017&amp;rft_id=https%3A%2F%2Fawards.cphi.com%2Fwinners%2F2017-winners%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://theeuropas.com/2017/06/16/the-hottest-tech-startups-of-2017-rocked-london-at-the-europas-awards/\" rel=\"nofollow\">\"THE HOTTEST TECH STARTUPS OF 2017 ROCKED LONDON AT THE EUROPAS AWARDS\"</a>. <i>The Europas</i>. The Europas<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Europas&amp;rft.atitle=THE+HOTTEST+TECH+STARTUPS+OF+2017+ROCKED+LONDON+AT+THE+EUROPAS+AWARDS&amp;rft_id=https%3A%2F%2Ftheeuropas.com%2F2017%2F06%2F16%2Fthe-hottest-tech-startups-of-2017-rocked-london-at-the-europas-awards%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://cogx.co/2018-awards-finalists/\" rel=\"nofollow\">\"Awards Finalists\"</a>. <i>CogX</i>. CogX<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CogX&amp;rft.atitle=Awards+Finalists&amp;rft_id=https%3A%2F%2Fcogx.co%2F2018-awards-finalists%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a class=\"external text\" href=\"https://benevolent.ai/news/benevolentai-awarded-technology-pioneer-status-by-world-economic-forum\" rel=\"nofollow\">\"BenevolentAI Awarded Technology Pioneer Status by World Economic Forum\"</a>. <i>BenevolentAI</i>. BenevolentAI<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 November</span> 2018</span>.</cite><span class=\"Z3988\" title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BenevolentAI&amp;rft.atitle=BenevolentAI+Awarded+Technology+Pioneer+Status+by+World+Economic+Forum&amp;rft_id=https%3A%2F%2Fbenevolent.ai%2Fnews%2Fbenevolentai-awarded-technology-pioneer-status-by-world-economic-forum&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenevolentAI\"></span><link href=\"mw-data:TemplateStyles:r879151008\" rel=\"mw-deduplicated-inline-style\"/></span>\n</li>\n</ol></div></div>\n<!-- \nNewPP limit report\nParsed by mw1341\nCached time: 20190224174522\nCache expiry: 2073600\nDynamic content: false\nCPU time usage: 0.384 seconds\nReal time usage: 0.474 seconds\nPreprocessor visited node count: 1711/1000000\nPreprocessor generated node count: 0/1500000\nPost‐expand include size: 59321/2097152 bytes\nTemplate argument size: 697/2097152 bytes\nHighest expansion depth: 8/40\nExpensive parser function count: 2/500\nUnstrip recursion depth: 1/20\nUnstrip post‐expand size: 83740/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.212/10.000 seconds\nLua memory usage: 5.57 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  412.228      1 -total\n 53.90%  222.192      1 Template:Reflist\n 47.03%  193.870     28 Template:Cite_web\n 22.06%   90.926      1 Template:Infobox_company\n 17.75%   73.159      1 Template:Infobox\n  9.21%   37.956      1 Template:Advert\n  9.18%   37.851      1 Template:Short_description\n  8.59%   35.397      1 Template:Pagetype\n  8.33%   34.349      2 Template:Ambox\n  2.38%    9.818      1 Template:Br_separated_entries\n-->\n<!-- Saved in parser cache with key enwiki:pcache:idhash:58865653-0!canonical and timestamp 20190224174521 and revision id 884887073\n -->\n</div><noscript><img alt=\"\" height=\"1\" src=\"//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1\" style=\"border: none; position: absolute;\" title=\"\" width=\"1\"/></noscript></div> <div class=\"printfooter\">\n\t\t\t\t\t\tRetrieved from \"<a dir=\"ltr\" href=\"https://en.wikipedia.org/w/index.php?title=BenevolentAI&amp;oldid=884887073\">https://en.wikipedia.org/w/index.php?title=BenevolentAI&amp;oldid=884887073</a>\"\t\t\t\t\t</div>\n<div class=\"catlinks\" data-mw=\"interface\" id=\"catlinks\"><div class=\"mw-normal-catlinks\" id=\"mw-normal-catlinks\"><a href=\"/wiki/Help:Category\" title=\"Help:Category\">Categories</a>: <ul><li><a href=\"/wiki/Category:Artificial_intelligence\" title=\"Category:Artificial intelligence\">Artificial intelligence</a></li><li><a href=\"/wiki/Category:Companies_of_the_United_Kingdom\" title=\"Category:Companies of the United Kingdom\">Companies of the United Kingdom</a></li><li><a href=\"/wiki/Category:Health_informatics\" title=\"Category:Health informatics\">Health informatics</a></li></ul></div><div class=\"mw-hidden-catlinks mw-hidden-cats-hidden\" id=\"mw-hidden-catlinks\">Hidden categories: <ul><li><a href=\"/wiki/Category:Articles_with_short_description\" title=\"Category:Articles with short description\">Articles with short description</a></li><li><a href=\"/wiki/Category:Articles_with_a_promotional_tone_from_December_2018\" title=\"Category:Articles with a promotional tone from December 2018\">Articles with a promotional tone from December 2018</a></li><li><a href=\"/wiki/Category:All_articles_with_a_promotional_tone\" title=\"Category:All articles with a promotional tone\">All articles with a promotional tone</a></li><li><a href=\"/wiki/Category:Wikipedia_articles_with_undisclosed_paid_content_from_February_2019\" title=\"Category:Wikipedia articles with undisclosed paid content from February 2019\">Wikipedia articles with undisclosed paid content from February 2019</a></li></ul></div></div> <div class=\"visualClear\"></div>\n</div>\n</div>\n<div id=\"mw-navigation\">\n<h2>Navigation menu</h2>\n<div id=\"mw-head\">\n<div aria-labelledby=\"p-personal-label\" id=\"p-personal\" role=\"navigation\">\n<h3 id=\"p-personal-label\">Personal tools</h3>\n<ul>\n<li id=\"pt-anonuserpage\">Not logged in</li><li id=\"pt-anontalk\"><a accesskey=\"n\" href=\"/wiki/Special:MyTalk\" title=\"Discussion about edits from this IP address [n]\">Talk</a></li><li id=\"pt-anoncontribs\"><a accesskey=\"y\" href=\"/wiki/Special:MyContributions\" title=\"A list of edits made from this IP address [y]\">Contributions</a></li><li id=\"pt-createaccount\"><a href=\"/w/index.php?title=Special:CreateAccount&amp;returnto=BenevolentAI\" title=\"You are encouraged to create an account and log in; however, it is not mandatory\">Create account</a></li><li id=\"pt-login\"><a accesskey=\"o\" href=\"/w/index.php?title=Special:UserLogin&amp;returnto=BenevolentAI\" title=\"You're encouraged to log in; however, it's not mandatory. [o]\">Log in</a></li> </ul>\n</div>\n<div id=\"left-navigation\">\n<div aria-labelledby=\"p-namespaces-label\" class=\"vectorTabs\" id=\"p-namespaces\" role=\"navigation\">\n<h3 id=\"p-namespaces-label\">Namespaces</h3>\n<ul>\n<li class=\"selected\" id=\"ca-nstab-main\"><span><a accesskey=\"c\" href=\"/wiki/BenevolentAI\" title=\"View the content page [c]\">Article</a></span></li><li id=\"ca-talk\"><span><a accesskey=\"t\" href=\"/wiki/Talk:BenevolentAI\" rel=\"discussion\" title=\"Discussion about the content page [t]\">Talk</a></span></li> </ul>\n</div>\n<div aria-labelledby=\"p-variants-label\" class=\"vectorMenu emptyPortlet\" id=\"p-variants\" role=\"navigation\">\n<input aria-labelledby=\"p-variants-label\" class=\"vectorMenuCheckbox\" type=\"checkbox\"/>\n<h3 id=\"p-variants-label\">\n<span>Variants</span>\n</h3>\n<ul class=\"menu\">\n</ul>\n</div>\n</div>\n<div id=\"right-navigation\">\n<div aria-labelledby=\"p-views-label\" class=\"vectorTabs\" id=\"p-views\" role=\"navigation\">\n<h3 id=\"p-views-label\">Views</h3>\n<ul>\n<li class=\"collapsible selected\" id=\"ca-view\"><span><a href=\"/wiki/BenevolentAI\">Read</a></span></li><li class=\"collapsible\" id=\"ca-edit\"><span><a accesskey=\"e\" href=\"/w/index.php?title=BenevolentAI&amp;action=edit\" title=\"Edit this page [e]\">Edit</a></span></li><li class=\"collapsible\" id=\"ca-history\"><span><a accesskey=\"h\" href=\"/w/index.php?title=BenevolentAI&amp;action=history\" title=\"Past revisions of this page [h]\">View history</a></span></li> </ul>\n</div>\n<div aria-labelledby=\"p-cactions-label\" class=\"vectorMenu emptyPortlet\" id=\"p-cactions\" role=\"navigation\">\n<input aria-labelledby=\"p-cactions-label\" class=\"vectorMenuCheckbox\" type=\"checkbox\"/>\n<h3 id=\"p-cactions-label\"><span>More</span></h3>\n<ul class=\"menu\">\n</ul>\n</div>\n<div id=\"p-search\" role=\"search\">\n<h3>\n<label for=\"searchInput\">Search</label>\n</h3>\n<form action=\"/w/index.php\" id=\"searchform\">\n<div id=\"simpleSearch\">\n<input accesskey=\"f\" id=\"searchInput\" name=\"search\" placeholder=\"Search Wikipedia\" title=\"Search Wikipedia [f]\" type=\"search\"/><input name=\"title\" type=\"hidden\" value=\"Special:Search\"/><input class=\"searchButton mw-fallbackSearchButton\" id=\"mw-searchButton\" name=\"fulltext\" title=\"Search Wikipedia for this text\" type=\"submit\" value=\"Search\"/><input class=\"searchButton\" id=\"searchButton\" name=\"go\" title=\"Go to a page with this exact name if it exists\" type=\"submit\" value=\"Go\"/> </div>\n</form>\n</div>\n</div>\n</div>\n<div id=\"mw-panel\">\n<div id=\"p-logo\" role=\"banner\"><a class=\"mw-wiki-logo\" href=\"/wiki/Main_Page\" title=\"Visit the main page\"></a></div>\n<div aria-labelledby=\"p-navigation-label\" class=\"portal\" id=\"p-navigation\" role=\"navigation\">\n<h3 id=\"p-navigation-label\">Navigation</h3>\n<div class=\"body\">\n<ul>\n<li id=\"n-mainpage-description\"><a accesskey=\"z\" href=\"/wiki/Main_Page\" title=\"Visit the main page [z]\">Main page</a></li><li id=\"n-contents\"><a href=\"/wiki/Portal:Contents\" title=\"Guides to browsing Wikipedia\">Contents</a></li><li id=\"n-featuredcontent\"><a href=\"/wiki/Portal:Featured_content\" title=\"Featured content – the best of Wikipedia\">Featured content</a></li><li id=\"n-currentevents\"><a href=\"/wiki/Portal:Current_events\" title=\"Find background information on current events\">Current events</a></li><li id=\"n-randompage\"><a accesskey=\"x\" href=\"/wiki/Special:Random\" title=\"Load a random article [x]\">Random article</a></li><li id=\"n-sitesupport\"><a href=\"https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en\" title=\"Support us\">Donate to Wikipedia</a></li><li id=\"n-shoplink\"><a href=\"//shop.wikimedia.org\" title=\"Visit the Wikipedia store\">Wikipedia store</a></li> </ul>\n</div>\n</div>\n<div aria-labelledby=\"p-interaction-label\" class=\"portal\" id=\"p-interaction\" role=\"navigation\">\n<h3 id=\"p-interaction-label\">Interaction</h3>\n<div class=\"body\">\n<ul>\n<li id=\"n-help\"><a href=\"/wiki/Help:Contents\" title=\"Guidance on how to use and edit Wikipedia\">Help</a></li><li id=\"n-aboutsite\"><a href=\"/wiki/Wikipedia:About\" title=\"Find out about Wikipedia\">About Wikipedia</a></li><li id=\"n-portal\"><a href=\"/wiki/Wikipedia:Community_portal\" title=\"About the project, what you can do, where to find things\">Community portal</a></li><li id=\"n-recentchanges\"><a accesskey=\"r\" href=\"/wiki/Special:RecentChanges\" title=\"A list of recent changes in the wiki [r]\">Recent changes</a></li><li id=\"n-contactpage\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\" title=\"How to contact Wikipedia\">Contact page</a></li> </ul>\n</div>\n</div>\n<div aria-labelledby=\"p-tb-label\" class=\"portal\" id=\"p-tb\" role=\"navigation\">\n<h3 id=\"p-tb-label\">Tools</h3>\n<div class=\"body\">\n<ul>\n<li id=\"t-whatlinkshere\"><a accesskey=\"j\" href=\"/wiki/Special:WhatLinksHere/BenevolentAI\" title=\"List of all English Wikipedia pages containing links to this page [j]\">What links here</a></li><li id=\"t-recentchangeslinked\"><a accesskey=\"k\" href=\"/wiki/Special:RecentChangesLinked/BenevolentAI\" rel=\"nofollow\" title=\"Recent changes in pages linked from this page [k]\">Related changes</a></li><li id=\"t-upload\"><a accesskey=\"u\" href=\"/wiki/Wikipedia:File_Upload_Wizard\" title=\"Upload files [u]\">Upload file</a></li><li id=\"t-specialpages\"><a accesskey=\"q\" href=\"/wiki/Special:SpecialPages\" title=\"A list of all special pages [q]\">Special pages</a></li><li id=\"t-permalink\"><a href=\"/w/index.php?title=BenevolentAI&amp;oldid=884887073\" title=\"Permanent link to this revision of the page\">Permanent link</a></li><li id=\"t-info\"><a href=\"/w/index.php?title=BenevolentAI&amp;action=info\" title=\"More information about this page\">Page information</a></li><li id=\"t-wikibase\"><a accesskey=\"g\" href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q60750092\" title=\"Link to connected data repository item [g]\">Wikidata item</a></li><li id=\"t-cite\"><a href=\"/w/index.php?title=Special:CiteThisPage&amp;page=BenevolentAI&amp;id=884887073\" title=\"Information on how to cite this page\">Cite this page</a></li> </ul>\n</div>\n</div>\n<div aria-labelledby=\"p-coll-print_export-label\" class=\"portal\" id=\"p-coll-print_export\" role=\"navigation\">\n<h3 id=\"p-coll-print_export-label\">Print/export</h3>\n<div class=\"body\">\n<ul>\n<li id=\"coll-create_a_book\"><a href=\"/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=BenevolentAI\">Create a book</a></li><li id=\"coll-download-as-rdf2latex\"><a href=\"/w/index.php?title=Special:ElectronPdf&amp;page=BenevolentAI&amp;action=show-download-screen\">Download as PDF</a></li><li id=\"t-print\"><a accesskey=\"p\" href=\"/w/index.php?title=BenevolentAI&amp;printable=yes\" title=\"Printable version of this page [p]\">Printable version</a></li> </ul>\n</div>\n</div>\n<div aria-labelledby=\"p-lang-label\" class=\"portal\" id=\"p-lang\" role=\"navigation\">\n<h3 id=\"p-lang-label\">Languages</h3>\n<div class=\"body\">\n<ul>\n</ul>\n<div class=\"after-portlet after-portlet-lang\"><span class=\"wb-langlinks-add wb-langlinks-link\"><a class=\"wbc-editpage\" href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q60750092#sitelinks-wikipedia\" title=\"Add interlanguage links\">Add links</a></span></div> </div>\n</div>\n</div>\n</div>\n<div id=\"footer\" role=\"contentinfo\">\n<ul id=\"footer-info\">\n<li id=\"footer-info-lastmod\"> This page was last edited on 24 February 2019, at 17:45<span class=\"anonymous-show\"> (UTC)</span>.</li>\n<li id=\"footer-info-copyright\">Text is available under the <a href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License\" rel=\"license\">Creative Commons Attribution-ShareAlike License</a><a href=\"//creativecommons.org/licenses/by-sa/3.0/\" rel=\"license\" style=\"display:none;\"></a>;\nadditional terms may apply.  By using this site, you agree to the <a href=\"//foundation.wikimedia.org/wiki/Terms_of_Use\">Terms of Use</a> and <a href=\"//foundation.wikimedia.org/wiki/Privacy_policy\">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href=\"//www.wikimediafoundation.org/\">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>\n</ul>\n<ul id=\"footer-places\">\n<li id=\"footer-places-privacy\"><a class=\"extiw\" href=\"https://foundation.wikimedia.org/wiki/Privacy_policy\" title=\"wmf:Privacy policy\">Privacy policy</a></li>\n<li id=\"footer-places-about\"><a href=\"/wiki/Wikipedia:About\" title=\"Wikipedia:About\">About Wikipedia</a></li>\n<li id=\"footer-places-disclaimer\"><a href=\"/wiki/Wikipedia:General_disclaimer\" title=\"Wikipedia:General disclaimer\">Disclaimers</a></li>\n<li id=\"footer-places-contact\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\">Contact Wikipedia</a></li>\n<li id=\"footer-places-developers\"><a href=\"https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute\">Developers</a></li>\n<li id=\"footer-places-cookiestatement\"><a href=\"https://foundation.wikimedia.org/wiki/Cookie_statement\">Cookie statement</a></li>\n<li id=\"footer-places-mobileview\"><a class=\"noprint stopMobileRedirectToggle\" href=\"//en.m.wikipedia.org/w/index.php?title=BenevolentAI&amp;mobileaction=toggle_view_mobile\">Mobile view</a></li>\n</ul>\n<ul class=\"noprint\" id=\"footer-icons\">\n<li id=\"footer-copyrightico\">\n<a href=\"https://wikimediafoundation.org/\"><img alt=\"Wikimedia Foundation\" height=\"31\" src=\"/static/images/wikimedia-button.png\" srcset=\"/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x\" width=\"88\"/></a> </li>\n<li id=\"footer-poweredbyico\">\n<a href=\"//www.mediawiki.org/\"><img alt=\"Powered by MediaWiki\" height=\"31\" src=\"/static/images/poweredby_mediawiki_88x31.png\" srcset=\"/static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x\" width=\"88\"/></a> </li>\n</ul>\n<div style=\"clear: both;\"></div>\n</div>\n<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgPageParseReport\":{\"limitreport\":{\"cputime\":\"0.384\",\"walltime\":\"0.474\",\"ppvisitednodes\":{\"value\":1711,\"limit\":1000000},\"ppgeneratednodes\":{\"value\":0,\"limit\":1500000},\"postexpandincludesize\":{\"value\":59321,\"limit\":2097152},\"templateargumentsize\":{\"value\":697,\"limit\":2097152},\"expansiondepth\":{\"value\":8,\"limit\":40},\"expensivefunctioncount\":{\"value\":2,\"limit\":500},\"unstrip-depth\":{\"value\":1,\"limit\":20},\"unstrip-size\":{\"value\":83740,\"limit\":5000000},\"entityaccesscount\":{\"value\":1,\"limit\":400},\"timingprofile\":[\"100.00%  412.228      1 -total\",\" 53.90%  222.192      1 Template:Reflist\",\" 47.03%  193.870     28 Template:Cite_web\",\" 22.06%   90.926      1 Template:Infobox_company\",\" 17.75%   73.159      1 Template:Infobox\",\"  9.21%   37.956      1 Template:Advert\",\"  9.18%   37.851      1 Template:Short_description\",\"  8.59%   35.397      1 Template:Pagetype\",\"  8.33%   34.349      2 Template:Ambox\",\"  2.38%    9.818      1 Template:Br_separated_entries\"]},\"scribunto\":{\"limitreport-timeusage\":{\"value\":\"0.212\",\"limit\":\"10.000\"},\"limitreport-memusage\":{\"value\":5842115,\"limit\":52428800}},\"cachereport\":{\"origin\":\"mw1341\",\"timestamp\":\"20190224174522\",\"ttl\":2073600,\"transientcontent\":false}}});});</script>\n<script type=\"application/ld+json\">{\"@context\":\"https:\\/\\/schema.org\",\"@type\":\"Article\",\"name\":\"BenevolentAI\",\"url\":\"https:\\/\\/en.wikipedia.org\\/wiki\\/BenevolentAI\",\"sameAs\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q60750092\",\"mainEntity\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q60750092\",\"author\":{\"@type\":\"Organization\",\"name\":\"Contributors to Wikimedia projects\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Wikimedia Foundation, Inc.\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\/\\/www.wikimedia.org\\/static\\/images\\/wmf-hor-googpub.png\"}},\"datePublished\":\"2018-10-24T09:04:55Z\",\"dateModified\":\"2019-02-24T17:45:21Z\"}</script>\n<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgBackendResponseTime\":101,\"wgHostname\":\"mw1324\"});});</script>\n</body>\n</html>\n",
  "table_of_contents": [
    "1 Company history",
    "2 Solutions and services",
    "3 BenevolentAI Award",
    "4 Awards and recognitions",
    "5 References"
  ],
  "graphics": [],
  "paragraphs": [
    {
      "title": "",
      "text": "BenevolentAI is a UK-based artificial intelligence company. They operate under the mission to change the way medicine is designed, developed, tested, and delivered to the market using computational medicine and AI technology.[1] It is a fully integrated AI company with pharmaceutical discovery and clinical development capabilities.[2]\n\nThe company has developed the Benevolent Platform, an end-to-end computational and experimental platform for drug discovery; BenevolentAI scientists use the platform to find new ways to treat disease and personalise drugs to patients.[3] The Benevolent Platform continuously ingests and analyses unstructured and structured biomedical information, from academic papers to compound databases, to clinical trials, to scientific patents. This information is combined with deep learning to create a bioscience knowledge graph coupled with an automated platform for hypothesis generation and validation followed by the design, refinement and synthesis of molecules.[4]\n\n"
    },
    {
      "title": "Company history",
      "text": "BenevolentAI was founded in November 2013 by Ken Mulvany.[5] Initially the company focussed on the development of a cross functional AI technology to incorporate basic science, chemistry and clinical components and designed a system that could ingest, read and contextualise the world’s available bioscience information.[6]\n\nThroughout the course of 2014 and 2015 the technology was further developed to also reason and propose hypotheses to treat disease. By 2015, the company had raised $87 million in funding, including investors like Woodford Investment Management and Lansdowne Partners.[7] In 2015 BenevolentAI began to fully apply its technology to drug discovery and development and announced the appointment of Jackie Hunter to lead bioscience research at the company.[8]\n\nDuring 2016 further early drug R&D programmes were established and an in-license deal completed with J&J for novel clinical stage drug candidates.[9] That year BenevolentAI also initiated their first full drug programmes for ALS, and indicated in a later press release positive results from the initial data.[10]\n\n\n2017 saw the company file its first Investigational New Drug (IND) application. In February 2018, BenevolentAI acquired a Cambridge research facility in order to expand its capabilities across the entire drug discovery process. Two months later the company announced a further round of funding for $115 million.[11] In May of 2018, the company announced it had appointed Joanna Shields as CEO.[12]\n\nThe company is presently headquartered in Warren Street, London with a research facility in Cambridge (UK) and additional offices based in New York and Belgium.[13] On keeping the company headquartered in London, founder Mulvany has said “There's a real opportunity to build a business in this country, and there's an opportunity for the country to lead this sector, and all the pieces are in place. We've got incredible scientists, incredible mathematicians, we're able to draw all these people into London.\"[14] BenevolentAI has active R&D drug programmes from discovery to PhaseIIb in disease areas such as ALS, Parkinson’s, ulcerative colitis and sarcopenia.[15]\nHorizons Ventures advisor Bart Swanson is a board member; shareholders include Richard Farleigh, a high profile angel investor.[16]\n\n"
    },
    {
      "title": "Solutions and services",
      "text": "In 2016 BenevolentAI became the first European company to use a deep learning supercomputer to assist in the process of drug discovery, using the DGX-1 supercomputer to support its Judgment Augmented Correlation System (JACS).[17] The BenevolentAI Platform ingests data, reads, synthesizes, and contextualises data to determine the cause of a disease, proposes a drug target, makes a molecule to treat that disease and then defines the right patients to test that molecule in to drive greater clinical success.[18]\n\nTheir Platform is specifically used to design new molecules and extract hypotheses based on a knowledge graph detailing the relationships between genes, targets, diseases, proteins, and drugs.[19] The company has announced it is working with the Sheffield Institute of Translational Neuroscience on a treatment for ALS.[20]\n\n"
    },
    {
      "title": "BenevolentAI Award",
      "text": "In 2017 BenevolentAI announced the creation of the BenevolentAI Award, in partnership with the Association of Medical Research Charities. The award is given to a single applicant a year, allowing the winner to access the company’s technology to accelerate their medical research using artificial intelligence.[21]\n\nThe winner of the 2018 award was a collaboration between the Parkinson’s UK and The Cure Parkinson’s Trust. Upon receiving the award, the group announced their aim to identify three treatments that can be repurposed for Parkinson’s and two novel drug targets.[22]\n\n"
    }
  ],
  "links": []
}